000 01504 a2200469 4500
005 20250516232648.0
264 0 _c20141111
008 201411s 0 0 eng d
022 _a1791-7530
040 _aNLM
_beng
_cNLM
100 1 _aMehlhorn, Grit
245 0 0 _aHPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
_h[electronic resource]
260 _bAnticancer research
_cSep 2014
300 _a5127-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntibodies, Viral
_ximmunology
650 0 4 _aCapsid Proteins
_xgenetics
650 0 4 _aCase-Control Studies
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHuman papillomavirus 16
_ximmunology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOncogene Proteins, Viral
_xgenetics
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aRemission Induction
650 0 4 _aTreatment Outcome
650 0 4 _aUterine Cervical Neoplasms
_ximmunology
650 0 4 _aYoung Adult
650 0 4 _aUterine Cervical Dysplasia
_ximmunology
700 1 _aHautmann, Simone K
700 1 _aKoch, Martin C
700 1 _aStrehl, Johanna D
700 1 _aHartmann, Arndt
700 1 _aHilfrich, Ralf
700 1 _aBeckmann, Matthias W
700 1 _aGriesser, Henrik
773 0 _tAnticancer research
_gvol. 34
_gno. 9
_gp. 5127-32
999 _c24172338
_d24172338